STERIS' (STE) Albert Browne Receives FDA Warning Letter Related to Chemical Indicators Made in the UK

Article Stock Quotes (1) Comments (0)

In a Form 8-K dated May 31st but just filed with the SEC, STERIS (NYSE: STE) disclosed the company's Albert Browne Limited subsidiary received a warning letter from the U.S. Food and Drug Administration regarding chemical indicators manufactured in the United Kingdom. These devices are intended for the monitoring of certain sterilization and other processes.

The FDA warning letter states that the Agency has raised concerns regarding operational business processes. We do not believe that the concerns are related to product performance and are not a result of Customer complaints. We continue to work with the FDA to resolve the issues raised as diligently as possible. We do not currently believe that the impact of this event will have a material adverse effect on our financial results.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Merck (MRK) Says Efficacy Not Achieved in Preladenant Phase 3s; Will Discontinue
• AMD (AMD) Looks to Outdo Intel (INTC) in Battle of Performance Tablets with Latest SoC Offerings
• Sprint (S), SoftBank Receive Final State Regulatory Approval in Proposed Deal

Create E-mail Alert Related Categories

Corporate News, FDA

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?